BioCentury
ARTICLE | Company News

Daiichi Sankyo, Dana-Farber Cancer Institute deal

October 17, 2016 7:00 AM UTC

Daiichi partnered with the institute to develop a “translational pharmacology package” to treat lung cancer, which includes animal- and patient-derived xenograft models from the institute and translat...